American Thyroid Association® Satellite Symposium: Personalized Approach to Thyroid Disorders

American Thyroid Association® Satellite Symposium: Personalized Approach to Thyroid Disorders


Update 3/12/2020: The American Thyroid Association has been closely monitoring the COVID-19 situation. We are committed to taking appropriate precautions to ensure the health and safety of our members, event participants, staff, stakeholders, their families and those they serve. The March 27, 2020 ATA satellite program was connected to event logistics provided as part of the Endocrine Society Annual Meeting (ENDO 2020). The Endocrine Society cancelled their annual meeting. As such, ATA has cancelled the in-person Personalized Approach to Thyroid Disorders satellite program scheduled for March 27, 2020 in San Francisco, CA. We will deliver the satellite symposium in a virtual format at a later date. We will provide updates here as we have updates on our plans. Any refund requests should be directed to the Endocrine Society registration team as ENDO has managed the collection of registration fees for the ATA satellite symposium. Please visit the ENDO 2020 website here for updates. 


CDC Guidance on Steps to Prevent COVID-19 Illness

WHO COVID-19 Advice for the Public

Latest Information from the CDC on COVID-19

Latest Information from WHO on COVID-19

U.S. Department of State COVID-19 Travel Advisories

ATA® Satellite Symposium Program Committee

View the Meeting Faculty

Meet the ATA Board of Directors


Program Description

The management of thyroid disorders is becoming increasingly complex as clinicians and patients strive to develop individualized diagnostic and therapeutic strategies designed to balance evidence-based medicine with patient-specific characteristics and rising health care costs, while attempting to achieve excellent clinical outcomes. Varying reference ranges according to age, race, and body mass index in pregnant and non-pregnant populations have caused physicians to re-evaluate traditional therapeutic approaches to include alternative algorithms that fit the specific population they treat. Similarly, the risk-adapted information provided by long-term studies of microcarcinomas and new developments in the molecular characterization of tumors have allowed patients to consider limited surgeries and even active surveillance strategies that deviate from the traditional recommendation of aggressive management of thyroid cancer. Through a combination of lectures, panel discussions, and case-based presentations, we will examine the most important, and often controversial, management issues faced by clinicians across the full spectrum of thyroid disorders. Ultimately the goal of this Symposium is to provide participants the tools to design a personalized, patient-centered approach to the care of patients with thyroid disorders.

Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Describe demographic factors that make clinicians evaluate pregnant patients for treatment of thyroid disorders.
  • Explain the indications, risks, and benefits of treating pregnant patients with thyroid disease.
  • Understand the specific concerns to be taken into account when evaluating thyroid diseases in the pediatric and adolescent population.
  • Explain challenging scenarios in the treatment of patients with hypothyroidism after thyroidectomy and autoimmune hypothyroidism.
  • Illustrate different therapeutic strategies to manage patients with hyperthyroidism according to the etiology of their disease.
  • Understand the utility of decision-support tools to help patients and physicians discuss different treatment modalities in the management of hyperthyroidism and thyroid cancer.
  •  Identify the specific scenarios in which molecular testing of tumors becomes informative and provides the basis for an individualized therapeutic strategy.

We look forward to your participation

ATA President Martha Zeiger, M.D. Invites you to the 2020 American Thyroid Association Meetings

Join the ATA:

ATA Secretary/Chief Operating Officer Jacqueline Jonklaas, M.D. invites you to Join the ATA®